MARTEK BIOSCIENCES CORP Research and Development Expense
MARTEK BIOSCIENCES CORP reported Research and Development Expense of $33.56 million for the 12-month period ending 2010-10-31, per its 10-K filed 2010-12-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2010-12-29
- MARTEK BIOSCIENCES CORP research and development expense for the quarter ending 2010-10-31 was $9.17M, a 32.19% increase year-over-year.
- MARTEK BIOSCIENCES CORP research and development expense for the quarter ending 2010-07-31 was $8.50M, a 28.69% increase year-over-year.
- MARTEK BIOSCIENCES CORP research and development expense for the quarter ending 2009-10-31 was $6.94M.
- MARTEK BIOSCIENCES CORP research and development expense for the quarter ending 2009-07-31 was $6.60M.
- MARTEK BIOSCIENCES CORP research and development expense for fiscal 2010 was $33.56M, a 22.26% increase from fiscal 2009.
- MARTEK BIOSCIENCES CORP research and development expense for fiscal 2009 was $27.45M, a 4.67% increase from fiscal 2008.
- MARTEK BIOSCIENCES CORP research and development expense for fiscal 2008 was $26.22M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2010-10-31 | $9.17M derived: 10-K 12 month − 10-Q 9 month · filed 2010-12-29 | $17.67M derived: sum of 2 quarters · filed 2010-12-29 | $33.56M 10-K · filed 2010-12-29 | |
| 2010-07-31 | $8.50M 10-Q · filed 2010-09-08 | $24.39M 10-Q · filed 2010-09-08 | ||
| 2009-10-31 | $6.94M derived: 10-K 12 month − 10-Q 9 month · filed 2010-12-29 | $13.54M derived: sum of 2 quarters · filed 2010-12-29 | $27.45M 10-K · filed 2010-12-29 | |
| 2009-07-31 | $6.60M 10-Q · filed 2010-09-08 | $20.51M 10-Q · filed 2010-09-08 | ||
| 2008-10-31 | $26.22M 10-K · filed 2010-12-29 |